4//SEC Filing
BRADY ANN 4
Accession 0001415889-22-001693
CIK 0001583107other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:18 PM ET
Size
4.8 KB
Accession
0001415889-22-001693
Insider Transaction Report
Form 4
BRADY ANN
President, TBIL
Transactions
- Tax Payment
Ordinary Shares
2022-02-18$9.61/sh−8,369$80,426→ 110,319 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001767974
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 6:18 PM ET
- Size
- 4.8 KB